Hongtao Diao

606 total citations · 1 hit paper
20 papers, 402 citations indexed

About

Hongtao Diao is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hongtao Diao has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hongtao Diao's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Inflammasome and immune disorders (4 papers). Hongtao Diao is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers) and Inflammasome and immune disorders (4 papers). Hongtao Diao collaborates with scholars based in China, Australia and Russia. Hongtao Diao's co-authors include Xiaoqi Shao, Jiao Guo, Xianglu Rong, Meiling Yan, Dongwei Wang, Wenru Zeng, Qing Wang, Lun Li, Yue Zhang and Yun Li and has published in prestigious journals such as British Journal of Pharmacology, Journal of Ethnopharmacology and Antioxidants and Redox Signaling.

In The Last Decade

Hongtao Diao

19 papers receiving 399 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice

2022 160 citations Meiling Yan, Yun Li et al. Cell Death Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongtao Diao China	11	288	113	89	65	47	20	402
Xiaoqi Shao China	12	339 1.2×	129 1.1×	89 1.0×	64 1.0×	58 1.2×	20	436
Zhulan Cai China	12	251 0.9×	62 0.5×	127 1.4×	63 1.0×	53 1.1×	16	425
Jia Hu China	6	360 1.3×	77 0.7×	108 1.2×	73 1.1×	56 1.2×	8	463
Ranchen Xu China	6	351 1.2×	85 0.8×	34 0.4×	179 2.8×	41 0.9×	7	463
Amit Gupta India	10	265 0.9×	43 0.4×	46 0.5×	113 1.7×	22 0.5×	21	381
Veena Dhawan India	11	124 0.4×	80 0.7×	42 0.5×	39 0.6×	47 1.0×	17	369
Zhaohui Qiu China	14	249 0.9×	66 0.6×	183 2.1×	105 1.6×	65 1.4×	28	553
Zihong Wu China	9	127 0.4×	39 0.3×	43 0.5×	39 0.6×	55 1.2×	18	343
Huimin Gu China	10	191 0.7×	39 0.3×	192 2.2×	101 1.6×	78 1.7×	21	492

Countries citing papers authored by Hongtao Diao

Since Specialization

Citations

This map shows the geographic impact of Hongtao Diao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongtao Diao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongtao Diao more than expected).

Fields of papers citing papers by Hongtao Diao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongtao Diao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongtao Diao. The network helps show where Hongtao Diao may publish in the future.

Co-authorship network of co-authors of Hongtao Diao

This figure shows the co-authorship network connecting the top 25 collaborators of Hongtao Diao. A scholar is included among the top collaborators of Hongtao Diao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongtao Diao. Hongtao Diao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shao, Xiaoqi, Hongtao Diao, Dongwei Wang, et al.. (2025). The impact of YTHDF2-mediated NCOA4 methylation on myocardial ferroptosis. APOPTOSIS. 30(5-6). 1453–1466. 1 indexed citations

Wu, Han, et al.. (2025). Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives. Biomedicine & Pharmacotherapy. 185. 117978–117978.

Zhang, Yue, Hongtao Diao, Xu Li, et al.. (2025). YTHDF3-mediated FLCN/cPLA2 axis improves cardiac fibrosis via suppressing lysosomal function. Acta Pharmacologica Sinica. 46(5). 1262–1274. 1 indexed citations

Wu, Han, Weitao Jiang, Ping Pang, et al.. (2024). m6A reader YTHDF1 promotes cardiac fibrosis by enhancing AXL translation. Frontiers of Medicine. 18(3). 499–515. 3 indexed citations

Zhang, Feng, et al.. (2024). Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China. British Journal of Pharmacology. 182(20). 4741–4760. 4 indexed citations

Shao, Xiaoqi, Wenru Zeng, Qing Wang, et al.. (2024). Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques. Journal of Ethnopharmacology. 324. 117705–117705. 4 indexed citations

Diao, Hongtao, et al.. (2023). The m6A Reader YTHDF1 Promotes Lung Carcinoma Progression via Regulating Ferritin Mediate Ferroptosis in an m6A-Dependent Manner. Pharmaceuticals. 16(2). 185–185. 13 indexed citations

Pang, Ping, Wei Si, Han Wu, et al.. (2023). YTHDF2 Promotes Cardiac Ferroptosis via Degradation of SLC7A11 in Cardiac Ischemia–Reperfusion Injury. Antioxidants and Redox Signaling. 40(16-18). 889–905. 17 indexed citations

Yan, Meiling, Suping Liu, Wenru Zeng, et al.. (2023). The Chinese herbal medicine Fufang Zhenzhu Tiaozhi ameliorates diabetic cardiomyopathy by regulating cardiac abnormal lipid metabolism and mitochondrial dynamics in diabetic mice. Biomedicine & Pharmacotherapy. 164. 114919–114919. 15 indexed citations

10.

Zhang, Yue, Hongtao Diao, Dongwei Wang, et al.. (2023). Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA. Journal of Ethnopharmacology. 317. 116766–116766. 12 indexed citations

11.

Shao, Xiaoqi, Xueying Huang, Hongtao Diao, et al.. (2022). Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 3 indexed citations

12.

Zhang, Yue, Zhiying Wang, Jingjing Zhao, et al.. (2022). MicroRNA-24-3p alleviates cardiac fibrosis by suppressing cardiac fibroblasts mitophagy via downregulating PHB2. Pharmacological Research. 177. 106124–106124. 42 indexed citations

13.

Shao, Xiaoqi, et al.. (2022). The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 3 indexed citations

14.

Yan, Meiling, Yun Li, Wenru Zeng, et al.. (2022). Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice. Cell Death Discovery. 8(1). 258–258. 160 indexed citations breakdown →

15.

Zhang, Yue, Dongwei Wang, Ruonan Wang, et al.. (2022). FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway. Biomedicine & Pharmacotherapy. 148. 112696–112696. 12 indexed citations

16.

Diao, Hongtao, Xueying Huang, Xiaoqi Shao, et al.. (2022). The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against atherosclerosis by suppressing EndMT via modulating Akt1/β-catenin signaling pathway. Journal of Ethnopharmacology. 293. 115261–115261. 20 indexed citations

17.

Yan, Meiling, Lun Li, Xiaoqi Shao, et al.. (2022). The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation. Biomedicine & Pharmacotherapy. 148. 112709–112709. 24 indexed citations

18.

Diao, Hongtao, Dongwei Wang, Jingjing Zhao, et al.. (2022). BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation. Genes. 13(8). 1338–1338. 7 indexed citations

19.

Xiao, Dan, Yue Zhang, Yue Zhang, et al.. (2019). Emodin alleviates cardiac fibrosis by suppressing activation of cardiac fibroblasts via upregulating metastasis associated protein 3. Acta Pharmaceutica Sinica B. 9(4). 724–733. 45 indexed citations

20.

Hu, Yingying, Xi Chen, Zhange Li, et al.. (2019). MicroRNA‑1 downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60. Molecular Medicine Reports. 19(5). 3527–3536. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact